Novel combination markers for predicting progression of nonmuscle invasive bladder cancer.
about
Molecular substratification of bladder cancer: moving towards individualized patient managementBladder cancer: a simple model becomes complex.Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patientsDNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Overexpression of C16orf74 is involved in aggressive pancreatic cancers.Progression to T1 High Grade (T1HG) from a Lower Stage/Grade is Associated with Poorer Survival Outcomes than Initial Diagnosis with T1HG Bladder Cancer.
P2860
Novel combination markers for predicting progression of nonmuscle invasive bladder cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Novel combination markers for ...... uscle invasive bladder cancer.
@en
type
label
Novel combination markers for ...... uscle invasive bladder cancer.
@en
prefLabel
Novel combination markers for ...... uscle invasive bladder cancer.
@en
P2093
P2860
P356
P1476
Novel combination markers for predicting progression of nonmuscle invasive bladder cancer
@en
P2093
Gi-Young Kim
Hyung-Yoon Yoon
Isaac Yi Kim
Ji Sang Kim
Pildu Jeong
Sang-Cheol Lee
Sung-Kwon Moon
Tae-Hwan Kim
Wun-Jae Kim
Yun-Sok Ha
P2860
P304
P356
10.1002/IJC.27319
P577
2011-12-02T00:00:00Z